Dr. Johnston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
26 Hanson Street
Unit #1
Boston, MA 02118Phone+1 617-621-8348
Education & Training
- Duke University School of MedicineClass of 1977
Clinical Trials
- Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation Start of enrollment: 2006 Mar 01
- Trial of Linaclotide in Patients With Chronic Constipation Start of enrollment: 2008 Aug 01
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 199 citationsLinaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.Joel Castro, Andrea M. Harrington, Patrick A. Hughes, Christopher M. Martin, Pei Ge
Gastroenterology. 2013-12-01 - 169 citationsLinaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With ConstipationJeffrey M. Johnston, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Mark G. Currie
Gastroenterology. 2010-12-01 - 251 citationsTwo Randomized Trials of Linaclotide for Chronic ConstipationAnthony Lembo, Harvey Schneier, S J Shiff, Caroline B. Kurtz, James E. MacDougall
The New England Journal of Medicine. 2011-08-10
Press Mentions
- Ra Pharmaceuticals Strengthens Senior Management TeamMarch 1st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: